tirzepatide activates the GIP and GLP-1 incretin receptors and adds a glucose-dependent insulin-secretion effect that an amylin analog does not have
The reason: Last August, the FDA determined NAC can still be sold as a supplement
How GLP-1 medications may improve gut health GLP-1 receptor agonists have been demonstrated in preclinical and clinical trials to alter gut microbiota composition
it may vary depending on the compounding pharmacy
Studies show pp 332 effects on fat oxidation and inflammation make it useful for obesity, diabetes and fatty liver disease research
By: Staff July 31, 2026 July 31, 2026 12:00 Considerations for federally regulated employers with upcoming right-to-disconnect legislation With upcoming legislation requiring federally regulated employers to implement right-to-disconnect policies, David Whitten, employment lawyer and partner at Whitten & Lublin, is encouraging employers to start